Testosterone and Prostate Cancer: An Historical Perspective on a Modern Myth

This publication has 26 references indexed in Scilit:

• Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• Testosterone replacement therapy and the risk of prostate cancer: a perspective view
  International Journal Of Impotence Research, 2005
• Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• Prevention of Prostate Cancer by Androgens: Experimental Paradox or Clinical Reality
  European Urology, 2004
• Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial Neoplasia
  Journal of Urology, 2003
• High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study
  International Journal of Cancer, 2003
• Followup Interval Prostate Biopsy 3 Years After Diagnosis of High Grade Prostatic Intraepithelial Neoplasia is Associated With High Likelihood of Prostate Cancer, Independent of Change in Prostate Specific Antigen Levels
  Journal of Urology, 2002
• THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCER
  Journal of Urology, 2001
• Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controls
  Clinical Endocrinology, 1994
• Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)
  New England Journal of Medicine, 1989